Related Experiment Video
Updated: Jun 24, 2026

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus (KSHV)
Published on: September 14, 2010
Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 targets MDM2 to deregulate the p53 tumor
Hye-Ra Lee1, Zsolt Toth, Young C Shin
1Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Harlyne J. Norris Cancer Research Tower, 1450 Biggy Street, Los Angeles, California 90033, USA.
Abstract:
Cells infected by viruses utilize interferon (IFN)-mediated and p53-mediated irreversible cell cycle arrest and apoptosis as part of the overall host surveillance mechanism to ultimately block viral replication and dissemination. Viruses, in turn, have evolved elaborate mechanisms to subvert IFN- and p53-mediated host innate immune responses. Kaposi's sarcoma-associated herpesvirus (KSHV) encodes several viral IFN regulatory factors (vIRF1 to vIRF4) within a cluster of loci, their functions being primarily to inhibit host IFN-mediated innate immunity and deregulate p53-mediated cell growth control. Despite its significant homology and similar genomic location to other vIRFs, vIRF4 is distinctive, as it does not target and antagonize host IFN-mediated signal transduction. Here, we show that KSHV vIRF4 interacts with the murine double minute 2 (MDM2) E3 ubiquitin ligase, leading to the reduction of p53, a tumor suppressor, via proteasome-mediated degradation. The central region of vIRF4 is required for its interaction with MDM2, which led to the suppression of MDM2 autoubiquitination and, thereby, a dramatic increase in MDM2 stability. Consequently, vIRF4 expression markedly enhanced p53 ubiquitination and degradation, effectively suppressing p53-mediated apoptosis. These results indicate that KSHV vIRF4 targets and stabilizes the MDM2 E3 ubiquitin ligase to facilitate the proteasome-mediated degradation of p53, perhaps to circumvent host growth surveillance and facilitate viral replication in infected cells. Taken together, the indications are that the downregulation of p53-mediated cell growth control is a common characteristic of the four KSHV vIRFs and that p53 is indeed a key factor in the host's immune surveillance program against viral infections.
Insights
Kaposi's sarcoma-associated herpesvirus vIRF4 protein targets MDM2, a ubiquitin ligase, to degrade the tumor suppressor p53. This viral mechanism circumvents host cell cycle arrest, aiding viral replication.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Viruses trigger host defenses like interferon (IFN) and p53 pathways to block replication.
- Kaposi's sarcoma-associated herpesvirus (KSHV) encodes viral IFN regulatory factors (vIRFs) to evade these immune responses.
- KSHV vIRF4 uniquely does not target IFN signaling but impacts p53 regulation.
Purpose of the Study:
- To investigate the mechanism by which KSHV vIRF4 affects host cell growth control.
- To elucidate the interaction between KSHV vIRF4 and the p53 pathway.
- To understand how KSHV vIRF4 contributes to viral evasion strategies.
Main Methods:
- Investigated the interaction between KSHV vIRF4 and MDM2 E3 ubiquitin ligase.
- Assessed the effect of vIRF4 on p53 ubiquitination and degradation.
- Analyzed the impact of vIRF4 on MDM2 stability and autoubiquitination.
Main Results:
- KSHV vIRF4 directly interacts with MDM2, stabilizing the ligase.
- vIRF4 binding suppresses MDM2 autoubiquitination, increasing MDM2 stability.
- vIRF4 expression enhances p53 ubiquitination and proteasomal degradation, inhibiting apoptosis.
- vIRF4 facilitates p53 downregulation, circumventing host surveillance.
Conclusions:
- KSHV vIRF4 targets and stabilizes MDM2 to promote p53 degradation.
- This mechanism allows KSHV to suppress p53-mediated apoptosis and enhance viral replication.
- Downregulation of p53 is a conserved strategy among KSHV vIRFs against host immunity.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway

